Marijuana: What the Evidence Shows at It Relates to the Impact of Use and What Can Be Learned from Washington State and Colorado.”
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Decriminalization of Personal Use of Psychoactive Substances
Decriminalization of Personal Use of Psychoactive Substances 2018 Position Statement Canadian Association of Social Workers Author: Canadian Association of Social Workers (CASW) - 2018 Page 1 ofColleen 7 Kennelly 2018 Position Statement This statement was originally written and released byCanadian the Canadian Public Associa Health tion of Social Workers Association. The Canadian Association of Social Workers reprints and adapts the original statement with permission. Founded in 1926, the Canadian Association of Social Workers (CASW) is the national association voice for the social work profession. CASW has adopted a pro-active approach to issues pertinent to social policy/social work. It produces and distributes timely information for its members, and special projects are initiated and sponsored. With its concern for social justice and its continued role in social advocacy, CASW is recognized and called upon both nationally and internationally for its social policy expertise. The mission of CASW is to promote the profession of social work in Canada and advance social justice. CASW is active in the International Federation of Social Workers (IFSW). Ce document est disponible en français Canadian Association of Social Workers (CASW) - 2018 Page 2 of 7 DECRIMINALIZATION OF PERSONAL USE OF PSYCHOACTIVE SUBSTANCES The use of illegal psychoactive substances (IPS) in Canada persists despite ongoing efforts to limit their consumption. Criminalization of those who use these substances remains the principal tool to control their use and is unsuccessful. An alternative approach – a public health approach – is required. Such an approach is being used to manage the ongoing opioid crisis through amendments to the Controlled Drugs and Substances Act and other related acts,1 including renewal of the Canadian Drugs and Substances Strategy. -
The Ethics of Psychedelic Medicine: a Case for the Reclassification of Psilocybin for Therapeutic Purposes
THE ETHICS OF PSYCHEDELIC MEDICINE: A CASE FOR THE RECLASSIFICATION OF PSILOCYBIN FOR THERAPEUTIC PURPOSES By Akansh Hans A thesis submitted to Johns Hopkins University in conformity with the requirements for the degree of Master of Bioethics Baltimore, Maryland May 2021 © 2021 Akansh Hans All Rights Reserved I. Abstract Our current therapeutic mental health paradigms have been unable to adequately handle the mental illness crisis we are facing. We ought to ‘use every tool in our toolbox’ to help individuals heal, and the tool we should be utilizing right now is Psilocybin. Although it is classified as a Schedule I drug, meaning that it is believed to have a high potential for abuse, no accepted medical uses, and a lack of safety when used under medical supervision, Psilocybin is not addictive and does not have a high potential for abuse when used safely under medical supervision. For these reasons alone, Psilocybin deserves a reclassification for therapeutic purposes. However, many individuals oppose Psilocybin-assisted psychotherapy on ethical grounds or due to societal concerns. These concerns include: a potential change in personal identity, a potential loss of human autonomy, issues of informed consent, safety, implications of potential increased recreational use, and distributive justice and fairness issues. Decriminalization, which is distinct from reclassification, means that individuals should not be incarcerated for the use of such plant medicines. This must happen first to stop racial and societal injustices from continuing as there are no inherently ‘good’ or ‘bad’ drugs. Rather, these substances are simply chemicals that humans have developed relationships with. As is shown in this thesis, the ethical implications and risks of psychedelic medicine can be adequately addressed and balanced, and the benefits of Psilocybin as a healing tool far outweigh the risks. -
Modeling a Transdisciplinary Approach to Current Research
NATIONAL HISPANIC SCIENCE NETWORK ON DRUG ABUSE Tenth Annual International Conference Modeling a Transdisciplinary Approach to Current Research Agendas September 30-October 2, 200 The Westin Canal Place New Orleans, Louisiana Mission Statement The National Hispanic Science Network on Drug Abuse is dedicated to improving the health of Hispanics by increasing the amount and quality of interdisciplinary translational research on drug abuse, and fostering the development of Hispanic scientists in drug abuse research. National Steering Committee Patricia E. Molina, M.D., Ph.D. William A. Vega, Ph.D. Chair, NHSN Vice-Chair, NHSN Richard Ashman Professor & Head Provost Professor & Director, Roybal Institute Department of Physiology University of Southern California Director, Alcohol & Drug Abuse Center Louisiana State University Health Sciences Center María Elena Icaza Medina-Mora, Ph.D. Chief Director, Department of Epidemiology Sergio Aguilar-Gaxiola, M.D., Ph.D. & Psychosocial Research, Instituto Nacional Professor of Clinical Internal Medicine & Director de Psiquiatría, Ramón de la Fuente, Mexico Center for Reducing Health Disparities (CRHD) University of California, Davis Laura O’Dell, Ph.D. Chair, Early Career Leadership Subcommittee Margarita Alegría, Ph.D. Assistant Professor Professor, Center for Multicultural Mental Health Department of Psychology Research University of Texas at El Paso Cambridge Health Alliance Steffanie A. Strathdee, Ph.D. Hortensia Amaro, Ph.D. Associate Dean of Global Health Sciences Associate Dean, Bouvé College of Health Sciences Harold Simon Professor & Chief Distinguished Professor of Health Sciences & Division of Global Public Health, Department Counseling Psychology of Medicine, University of California, San Diego Director, Institute on Urban Health Research Bouvé College of Health Sciences José Szapocznik, Ph.D. -
Cannabis (Sub)Culture, the Subcultural Repository, and Networked Mediation
SIMULATED SESSIONS: CANNABIS (SUB)CULTURE, THE SUBCULTURAL REPOSITORY, AND NETWORKED MEDIATION Nathan J. Micinski A Thesis Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF ARTS May 2014 Committee: Ellen Berry, Advisor Rob Sloane © 2014 Nathan Micinski All Rights Reserved iii ABSTRACT Ellen Berry, Advisor Subcultural theory is traditionally rooted in notions of social deviance or resistance. The criteria for determining who or what qualifies as subcultures, and the most effective ways to study them, are based on these assumptions. This project seeks to address these traditional modes of studying subcultures and discover ways in which their modification may lead to new understandings and ways of studying subcultures in the contemporary moment. This will be done by suggesting a change in the criteria of examining subcultures from that of deviance or resistance to identification with a collection of images, symbols, rituals, and narratives. The importance of this distinction is the ability to utilize the insights that studying subcultures can offer while avoiding the faults inherent in speaking for or at a subculture rather than with or from it. Beyond addressing theoretical concerns, this thesis aims to apply notions of subcultural theory to study the online community of Reddit, in particular, a subset known as r/trees–a virtual repository for those images, symbols, rituals, and narratives of cannabis subculture. R/trees illustrates the life and vibrancy of a unique subcultural entity, which to this point has evaded a cultural studies analysis. To that end, this project advocates for the importance of the cultural studies approach to analyzing cannabis subculture and further, to insert the findings of this study into that gap in the literature. -
Guide to Worker Safety and Health in the Marijuana Industry Marijuana Occupational Health and Safety Work Group January 2017
Guide to Worker Safety and Health in the Marijuana Industry Marijuana Occupational Health and Safety Work Group January 2017 colorado.gov/cdphe/marijuana-occupational-safety-health Guide to Worker Safety and Health in the Marijuana Industry: 2017 About this guide This guide is intended to help assist employers in the marijuana industry build occupational safety and health programs. While the foundation of this guide includes existing Colorado state and federal regulations, it is not a comprehensive guide to all of the regulations pertaining to occupational safety and health. It should be noted that this guide does not present any new occupational safety and health regulations for the marijuana industry. Marijuana cultivators, extractors, labs and retailers are required to adhere to all regulations established by the Colorado Department of Revenue’s Marijuana Enforcement Division (MED) https://www.colorado.gov/pacific/enforcement/laws-constitution-statutes-and-regulations-marijuana- enforcement. The marijuana industry in Colorado falls under federal OSHA jurisdiction and businesses must comply with OSHA regulations and recordkeeping requirements. In addition to OSHA regulations, marijuana businesses are required to comply with other state regulations including Colorado labor laws, Colorado workers’ compensation laws, Colorado hazardous waste laws, Colorado Pesticide Applicator’s Act, local fire codes, and other regulations that are specific to employment and labor as well as the production of retail and medical marijuana. Guide to Worker Safety and Health in the Marijuana Industry: 2017 About the Colorado Marijuana Occupational Health and Safety Work Group The Colorado Marijuana Occupational Health and Safety Work Group is a multidisciplinary group that was convened to draw on expertise and experiences of many professionals in the Colorado community. -
Duncan Liquor Law Letter May 2016
Duncan Liquor Law Letter May 2016 Looks different from prior newsletters? We are converting to a mobile device friendly format. DUNCAN LIQUOR LAW LETTER May, 2016 A monthly newsletter for the clients of R.E. "Tuck" Duncan, Attorney at Law Please forward as you deem appropriate. In this issue: Cullison v. KDOR decision RNDC Indicted On Federal Smuggling Charges, But CEO Proclaims Company's Innocence FROM TTB: LIQUOR WHOLESALER AND THREE EMPLOYEES INDICTED FOR $9 MILLION SCHEME TO SMUGGLE LIQUOR FDA EXTENDING AUTHORITIES TO ALL TOBACCO PRODUCTS, INCLUDING E-CIGARETTES, CIGARS, AND HOOKAH U.S. Officials Are Investigating Anheuser-Busch InBev McLane Determined to Distribute Alcohol in TX Reuters: Justice Department Investigating A-B Distributor Incentives A survey of 30 liquor stores in Connecticut found 90 percent were mislabeling wine ratings. Bourbon Maker Says It Didn't Abandon 'Stitzel' Trademark Why Alcohol Companies Oppose Legal Pot in Arizona, but Support it in Nevada Anheuser-Busch gets $150,000 fine for liquor law violations in Seattle What to expect from the federal overtime rules Main Tito's Case Dismissed Outback Assistant Managers Seek OT In FLSA Class Action 1 of 38 Duncan Liquor Law Letter May 2016 No. 114,170 IN THE COURT OF APPEALS OF THE STATE OF KANSAS CLAY DEAN CULLISON, Appellant, v. KANSAS DEPARTMENT OF REVENUE, Appellee. SYLLABUS BY THE COURT 1. The legislature has made a distinction regarding a law enforcement officer's breath test certification based on whether the driver fails the test or refuses the test. If the driver fails the test, the officer must certify that the driver was operating the vehicle before the Kansas Department of Revenue can suspend the person's driver's license. -
Legalization and Decriminalization of Cannabis |
AMERICAN MEDICAL ASSOCIATION YOUNG PHYSICIANS SECTION Resolution: 5 (A-19) Introduced by: Albert L. Hsu, MD Subject: Public Health Impacts and Unintended Consequences of Legalization and Decriminalization of Cannabis for Medicinal and Recreational Use Referred to: AMA-YPS Reference Committee 1 Whereas, AMA Policy D-95.969, “Cannabis Legalization for Medicinal Use,” states, in part, that 2 our AMA: “(2) believes that cannabis for medicinal use should not be legalized through the state 3 legislative, ballot initiative, or referendum process;” and 4 5 Whereas, AMA Policy H-95.924, “Cannabis Legalization for Recreational Use,” states, in part, 6 that our AMA: “(5) encourages local, state, and federal public health agencies to improve 7 surveillance efforts to ensure data is available on the short- and long-term health effects of 8 cannabis use;” and 9 10 Whereas, AMA Policy H-95.923, “Taxes on Cannabis Products,” states that “our AMA 11 encourages states and territories to allocate a substantial portion of their cannabis tax revenue 12 for public health purposes, including: substance abuse prevention and treatment programs, 13 cannabis-related educational campaigns, scientifically rigorous research on the health effects of 14 cannabis, and public health surveillance efforts;” and 15 16 Whereas, AMA Policy H-95.952, “Cannabis and Cannabinoid Research,” states, in part, that our 17 AMA: “(4) supports research to determine the consequences of long-term cannabis use, 18 especially among youth, adolescents, pregnant women, and women who are breastfeeding; -
(A-9-THC) Content in Herbal Cannabis Over Time
32 Current Drug Abuse Reviews, 2012, 5, 32-40 Increasing Delta-9-Tetrahydrocannabinol (-9-THC) Content in Herbal Cannabis Over Time: Systematic Review and Meta-Analysis Fidelia Cascini*,1, Carola Aiello2 and GianLuca Di Tanna3 1Istituto di Medicina Legale, Università Cattolica del S. Cuore, largo F. Vito, 1 00168 Roma, Italy 2Department of Informatics and Systemics, University ‘La Sapienza’, 00185 Rome, Italy 3Department of Public Health and Infectious Diseases, University "La Sapienza", 00185, Rome, Italy Abstract: Aim: The objective of this meta-analysis is to assess the data regarding changes in herbal cannabis potency over time (from 1970 to 2009). Methods: Systematic searches of 17 electronic scientific databases identified studies on this topic, within which 21 case series studies satisfied our inclusion criteria of reporting the mean tetrahydrocannabinol (THC) value per number of samples per year. No language, publication date, publication type or status restrictions were imposed. The study selection and data extraction processes were performed independently but uniformly by two authors, included screening, determination of eligibility and inclusion of the eligible studies in the systematic review, and a meta-analysis of the results on THC content in herbal cannabis samples. We considered papers and not monographic scientific publications, rejecting all studies that were not focused on the subject of this review. Results: Meta-analysis by year was performed on 21 studies containing 75 total mean THC observations from 1979 to 2009 using the random effects model. The results revealed much variability between studies. Further, there was a significant correlation between year and mean THC in herbal cannabis. The combined data indicated the correlation between year and mean THC in herbal cannabis, revealing a temporal trend of increasing potency (5% above the mean THC value in the Poisson regression analysis). -
Decriminalization of Marijuana and Potential Impact on CMV Drivers
Commercial Vehicle Safety Research Summit Decriminalization of Marijuana and Potential Impact on CMV Drivers Darrin T. Grondel, Director Washington Traffic Safety Commission November 09, 2016 Collaboration and Research SIGNS AND SYMPTOMS OF MJ IMPAIRMENT THC and similar compounds bind with receptors (CB1 and CB2) in the brain and other parts of the body affecting the function of the hippocampus (short-term memory), cerebellum (coordination) and basal ganglia (unconscious muscle movements). • Marijuana is a lipid (fat) soluble and tends to stay in the brain • Alcohol is water soluble - blood Reference - http://www.brainwaves.com/ SIGNS AND SYMPTOMS OF MARIJUANA Relaxation Mood changes, including Euphoria panic and paranoia with high dose Relaxed Inhibitions Heightened senses Disorientation Body tremors (Major Altered time & distance muscle groups: quads, perception gluts, and abs) Lack of Concentration Eyelid tremors Impaired Memory & Red, Bloodshot eyes comprehension Possible GVM or green Jumbled thought coating on tongue formation Dilated pupils Drowsiness CHALLENGES AND IMPACTS ON CMV Data – lack of good data on CMV crashes with DRE in WA and Nationally. Public indifference on the issue of drugged driving vs. Alcohol impairment Medical Marijuana– have all states adopted federal rules for Intrastate CMV operators? 49 CFR 382.60 – Supervisors required to attend 60 min of training for symptoms of alcohol abuse and another 60 min for controlled substances. A singular event no refresher. Is this enough? Refresher? Compare to LE? This training should have considerations for expansion with high prevalence of drugged driving. CVEO – trained in signs and symptoms (ARIDE or modified DRE). Can they identify potentially impaired drivers? National studies are focused on PV with little to no attention on CMV operators. -
(00:10): [Inaudible]
Speaker 1 (00:10): [inaudible] Speaker 2 (00:11): Hello and welcome to the higher enlightenment podcast brought to you by higher yields cannabis consulting, your seed to sale cannabis business solutions team, and the creators of the innovative cannabis consulting business solution system higher enlightenment. My name is Adam. I'm your host and part of the creative design team here at higher yields. Today's podcast is about decriminalization versus legalization. Let's start by having our panel of experts. Introduce themselves. Let's start with you, Chris. Could you tell us a little bit about your background and what you do? Speaker 1 (00:50): My name is Chris Teegarden. I'm the former mayor of Edgewater, Colorado, the first municipality in the world to codify and regulate recreational cannabis. I am the director of government affairs for higher yields consulting, a vertically integrated cannabis consulting company. Uh, while I was out in Denver as a mayor, uh, I also was vice chair of the first judicial criminal justice coordinating committee, uh, which encompassed two counties in the Denver Metro area and served about 600,000 people. And we were doing high level policy initiatives, uh, for that area and direct, uh, collaboration and working with the federal state and local jurisdictions. I was also the chair of the Metro mayor's caucus, homelessness and hunger committee, and the Metro mayor's caucus was a gathering and group of 42 mayors and the front range region talking about high level policy on many initiatives and criminal justice was also one of those initiatives. -
What Will Legal Marijuana Cost Employers?
What Will Legal Marijuana Cost Employers? National Families in Action ThisAtlanta, page intentionally Georgia left blank. 1 2 What Will Legal Marijuana Cost Employers? A White Paper By Sue Rusche and Kevin Sabet, PhD The purpose of National Families in Action’s White Paper is to educate employers about how marijuana laws are changing, how these laws will affect employers’ ability to conduct business, and what employers can do to protect that ability. We contracted with Kevin Sabet, co-founder of Project SAM (Smart Approaches to Marijuana), to help write the White Paper. To begin, we assembled a group of experts from various fields to advise us on how the changing legal landscape will affect employers. All agree that costs will increase as changing marijuana laws present new challenges. Employers need to anticipate those challenges and plan ways to maintain profitability, productivity, safety, and flexibility while litigation and case law sort out state laws that conflict with federal laws and from state to state. The adage that an ounce of prevention is worth a pound of cure has never been more relevant. Employers have a significant opportunity to monitor both marijuana ballot initiatives that advocates are proposing and bills that state legislators are writing to protect their interests and those of their employees and the public. Please see Appendix A for information about National Families in Action, Project SAM, and our expert advisors. We gratefully acknowledge The Bodman Foundation for providing a grant to National Families in Action, which made it possible to produce this White Paper. 3 This page intentionally left blank. -
House Plans Historic Vote on Federal Marijuana Legalization
Legal Sidebari The MORE Act: House Plans Historic Vote on Federal Marijuana Legalization November 25, 2020 In December 2020, the House of Representatives plans to vote on H.R. 3884, the Marijuana Opportunity Reinvestment and Expungement Act of 2019 (MORE Act). The MORE Act is also pending before the Senate. Among other things, the MORE Act would remove marijuana from the schedules of controlled substances under the Controlled Substances Act (CSA), legalizing many marijuana-related activities at the federal level. Commentators have noted that a vote on the MORE Act would be the first time the full House voted on a proposal to deschedule marijuana. This Legal Sidebar briefly summarizes the legal status of marijuana in the United States. It then outlines key provisions of the MORE Act before discussing selected considerations for Congress related to the bill. The Legal Status of Marijuana Under federal law, the plant Cannabis sativa L. and products derived from that plant are generally classified as marijuana, with a couple of exceptions. (The statute uses an archaic spelling, “marihuana,” that was more common when Congress enacted the CSA in 1970, but this Sidebar uses the currently accepted spelling, “marijuana.”) One key exception relates to hemp, a legal classification that includes cannabis and cannabis-derived products containing very low levels of the psychoactive cannabinoid delta- 9 tetrahydrocannabinol (THC). Hemp is not a controlled substance subject to the CSA, though it remains subject to other federal laws. Congress classified marijuana as a Schedule I controlled substance when it enacted the CSA, meaning that marijuana is subject to the most stringent level of federal control.